Literature DB >> 9875924

Has the mortality of septic shock changed with time.

G Friedman1, E Silva, J L Vincent.   

Abstract

OBJECTIVES: To determine whether a systematic review of the literature could identify changes in the mortality of septic shock over time. DATA SOURCES: A review of all relevant papers from 1958 to August 1997, identified through a MEDLINE search and from the bibliographies of articles identified. DATA SYNTHESIS: The search identified 131 studies (99 prospective and 32 retrospective) involving a total of 10,694 patients. The patients' mean age was 57 yrs with no change over time. The overall mortality rate in the 131 studies was 49.7%. There was an overall significant trend of decreased mortality over the period studied (r=.49, p < .05). The mortality rate in those patients with bacteremia as an entry criterion was greater than that rate in patients whose entry criterion was sepsis without definite bacteremia (52.1% vs. 49.1%; chi2=6.1 and p< .05). The site of infection altered noticeably over the years. Chest-related infections increased over time, with Gram-negative infections becoming proportionately less common. If all other organisms and mixed infections are included with the Gram-positives, the result is more dramatic, with these organisms being causative in just 10% of infections between 1958 and 1979 but in 31% of infections between 1980 and 1997.
CONCLUSIONS: The present review showed a slight reduction in mortality from septic shock over the years, although this result should be approached with caution. The heterogeneity of the articles and absence of a severity score for most of the studies limited our analysis. Furthermore, there was an increasing prevalence of Gram-positive causative organisms, and a change of the predominant origin of sepsis from the abdomen to the chest.

Entities:  

Mesh:

Year:  1998        PMID: 9875924     DOI: 10.1097/00003246-199812000-00045

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  129 in total

1.  Demystifying critical care: a new series provides a succinct, modern approach aimed at primary care physicians.

Authors:  R Rodriguez
Journal:  West J Med       Date:  2001-12

2.  Myocardial dysfunction in sepsis: no role for NO?

Authors:  E Belcher; J Mitchell; T Evans
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

Review 3.  [Shock--what are the basics?].

Authors:  U Janssens; J Graf
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

4.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

5.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

6.  Incidence of sepsis in hospitalized patients.

Authors:  Rui Moreno; Susana Afonso; Teresa Fevereiro
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

Review 7.  Should we inhibit type I interferons in sepsis?

Authors:  Tina Mahieu; Claude Libert
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

8.  Influence of diabetes on endothelial cell response during sepsis.

Authors:  P Schuetz; K Yano; M Sorasaki; L Ngo; M St Hilaire; J M Lucas; W Aird; N I Shapiro
Journal:  Diabetologia       Date:  2011-02-01       Impact factor: 10.122

9.  [Targeted cardiovascular therapy: shock treatment in ambulance, emergency room and intensive care unit].

Authors:  S Kluge; G Kreymann
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

Review 10.  The Collaborative Cross mouse model for dissecting genetic susceptibility to infectious diseases.

Authors:  Hanifa Abu Toamih Atamni; Aysar Nashef; Fuad A Iraqi
Journal:  Mamm Genome       Date:  2018-08-24       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.